28 Several states aim to expand Medicaid access for GLP1 coverage, although none of the proposals passed in 2025, and employer health plans are exploring innovative vendor partnerships and behavioral health integration to monitor usage
Providers and digital health companies should reassess marketing, supply chains, and pricing strategies to remain compliant
Studies with PYY agonists administered intravenously have shown reduction in food intake with increased satiety [92, 93], however, a nasal PYY agonist showed minimal efficacy with poor tolerability [94]
Januvia is designed to be used in combination with a healthy diet and regular exercise
5e), adipose tissue mass (Extended Data Fig
Analgesia accompanying food consumption requires ingestion of hedonic foods